Helios director converts 697 RSUs at $69.29
A HELIOS TECHNOLOGIES, INC. director settled 697 RSUs into 697 common shares at a reported $69.29 per share, with no Rule 10b5-1 trading plan indicated.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
HELIOS TECHNOLOGIES, INC. (HLIO) director Ian K. Walsh reported the vesting and settlement of 697 Restricted Stock Units into 697 shares of Common Stock on September 18, 2026. The RSUs were exercised at a reported value of $69.29 per share, leaving no RSUs from this award outstanding and 697 common shares held directly.
The RSUs each represented the right to receive one share of common stock upon vesting, with no expiration after vesting, and no transactions were reported under a Rule 10b5-1 trading plan.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Exercise | Restricted Stock Units F1 | 697 | $0.00 | $0.00 |
| Exercise | Common Stock | 697 | $69.29 | $48K |
Footnotes (1)
- F1. Each RSU represents the right to receive, following vesting, one share of Common Stock. Upon vesting, there is no expiration.
Key Figures
Key Terms
Restricted Stock Units financial
derivative security financial
Rule 10b5-1 regulatory
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What insider transaction did HLIO director Ian K. Walsh report?
What happened to the 697 Restricted Stock Units reported for HLIO?
Was a Rule 10b5-1 trading plan used for this HLIO Form 4 transaction?
AI-generated analysis. How Rhea-AI works. Not financial advice.